Author

E. Garralda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:flow cytometry· 1 Assay:imaging· 1

Frequent Co-Authors

A. Garcia-Garijo· 2 shared A. Gros· 2 shared A. Caballe· 1 shared A. Schlosser· 1 shared A. Vidal· 1 shared A. Yuste-Estevanez· 1 shared C. Stephan-Otto Attolini· 1 shared E. Caron· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Garcia-Garijo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immunogenicity of non-canonical HLA-tumor ligands identified through proteogenomics

M. Lozano-Rabella, A. Garcia-Garijo, J. Palomero, A. Yuste-Estevanez, F. Erhard, J. Martin-Liberal, M. Ochoa de Olza, I. Matos, J. J. Gartner, M. Ghosh, F. Canals, A. Vidal, J. M. Piulats, X. Matias-Guiu, I. Brana, , A. Gros

The paper investigates the immunogenicity of non-canonical HLA-I ligands from tumor cells and finds they are not recognized by autologous T-cells but can be targeted by donor T-cells, suggesting potential as immunotherapy targets.

bioRxiv · Nov 7, 2022Cancer Biology

Induction of senescence renders cancer cells highly immunogenic

I. Marin, O. Boix, A. Garcia-Garijo, i. Sirois, A. Caballe, E. Zarzuela, I. Ruano, C. Stephan-Otto Attolini, N. Prats, J. A. Lopez-Dominguez, M. Kovatcheva, E. Garralda, J. Munoz, E. Caron, M. Abad, , M. Serrano

This study shows that inducing senescence in cancer cells enhances their immunogenicity, leading to stronger anti-tumor immune responses compared to immunogenic cell death.

bioRxiv · Jun 5, 2022 · PreprintCancer Biology